The 21st International Vasculitis Workshop, organised by the IDIBAPS Systemic vasculitis research group at Barcelona International Convention Centre1
The award ceremony took place on 12 May as part of the 53rd Laurentian Conference of Rheumatology in Canada
This distinction is one of the highest honours awarded by the College to members who have made outstanding contributions to the field of rheumatology1
The administration of the antibody mavrilimumab in conjunction with prednisone reduces the risk of exacerbation of symptoms of the disease and improv1
Vasculitis is a group of rare autoimmune diseases that, until now, have mainly been treated with corticosteroids and other immunosuppressants. Cortic1
A study carried out at Hospital Clínic of Barcelona analysed the outcomes of patients with autoimmune disease and COVID-19 infection who were admitte1
